In order to understand the signaling mechanisms by which anti-Activin A and anti-TGF-β antibodies affect PAH PAVSMC growth and proliferation, we first evaluated phosphorylation status of Smads, a canonical downstream effectors of TGF-β superfamily [9]. Here, TGFB1 is linked to pulmonary arterial hypertension.